A Study of the Recombinant Human Interleukin-11 (I) (Baijieyi) for Prevention and Treatment of Chemotherapy-induced Thrombocytopenia in Patients With Malignant Tumor
Clinical trial NCT03049774 · UNKNOWN
Trial details
- NCT number
- NCT03049774
- Sponsor
- Angde Biotech Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2017-02-28
- Primary completion
- 2017-08-01
- Enrollment
- 2000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.